RACQUEL FUNG: Open Payments
NPI 1811545510 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 7 payments from 7 companies in 2025. Trend: 2023 $101 · 2024 $278 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $124 |
| ABBVIE INC. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $18 |
Products named: NUCALA, SKYRIZI, DUPIXENT, GEMTESA, Ocrevus Zunovo, TREMFYA, Leqembi.
Industry payments across VA — which companies pay providers there.
